AxoGen Raises $12.1M

AxoGen Inc., an Alachua, Fla.-based company that is commercializing peripheral nerve regeneration technologies, has raised $12.1 million in Series C funding from Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures and Springboard Capital II, according to Biotech Week. www.axogeninc.com